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Failure of Acute Ethanol Administration to Alter
Cerebrocortical and Hippocampal Allopregnanolone Levels
in C57BL/6J and DBA/2JMice
Patrizia Porcu, Andrea Locci, Francesca Santoru, Roberta Berretti, A. Leslie Morrow, and
Alessandra Concas
Background: Ethanol (EtOH) administration increases brain allopregnanolone levels in rats, and
this increase contributes to sensitivity to EtOH’s behavioral effects. However, EtOH’s effects on allo-
pregnanolone may differ across species. We investigated the effects of acute EtOH administration on
allopregnanolone, progesterone, and corticosterone levels in cerebral cortex and hippocampus of
C57BL/6J and DBA/2J mice, 2 inbred strains with different alcohol sensitivity.
Methods: Na€ıve male C57BL/6J and DBA/2J mice received EtOH (1, 2, 3, or 4 g/kg, intraperitone-
ally [i.p.]) or saline and were euthanized 1 hour later. For the time-course study, mice received EtOH
(2 g/kg, i.p.) and were euthanized 15, 30, 60, and 120 minutes later. Steroids were measured by radioim-
munoassay.
Results: Acute EtOH administration did not alter cerebrocortical and hippocampal levels of allo-
pregnanolone and progesterone in these strains at any of the doses and time points examined. Acute
EtOH dose-dependently increased cerebrocortical corticosterone levels by 319, 347, and 459% in
C57BL/6J mice at the doses of 2, 3, and 4 g/kg, and by 371, 507, 533, and 692% in DBA/2J mice at the
doses of 1, 2, 3, and 4 g/kg, respectively. Similar changes were observed in the hippocampus. EtOH’s
effects on cerebrocortical corticosterone levels were also time dependent in both strains. Moreover,
acute EtOH administration time-dependently increased plasma levels of progesterone and corticoste-
rone. Finally, morphine administration increased cerebrocortical allopregnanolone levels in C57BL/6J
(+77, +93, and +88% at 5, 10, and 30 mg/kg, respectively) and DBA/2J mice (+81% at 5 mg/kg),
suggesting that the impairment in brain neurosteroidogenesis may be specific to EtOH.
Conclusions: These results underline important species differences on EtOH-induced brain neuroste-
roidogenesis. Acute EtOH increases brain and plasma corticosterone levels but does not alter cerebro-
cortical and hippocampal concentrations of allopregnanolone and progesterone in na€ıve C57BL/6J and
DBA/2J mice.
Key Words: Allopregnanolone, Progesterone, Corticosterone, Ethanol, C57BL/6J and DBA/2J
Mice.
ALLOPREGNANOLONE, THE 3a,5a-reduced metab-olite of progesterone, is a neuroactive steroid that pro-
duces inhibitory neurobehavioral effects such as anxiolytic,
anticonvulsant, and sedative/hypnotic actions via interaction
with c-aminobutyric acid type A (GABAA) receptors (Biggio
and Purdy, 2001). Allopregnanolone concentrations are
altered in several neuropsychiatric disorders, including
anxiety, depression, premenstrual dysphoric disorder,
schizophrenia, and drug addiction (Biggio and Purdy, 2001;
Morrow et al., 2006). Allopregnanolone levels are increased
in rat brain and plasma by administration of various psycho-
active drugs, including ethanol (EtOH; Morrow et al., 1999),
caffeine (Concas et al., 2000), nicotine (Porcu et al., 2003),
tetrahydrocannabinol (Grobin et al., 2005), morphine
(Concas et al., 2006; Grobin et al., 2005), and gamma-
hydroxybutyric acid (Porcu et al., 2004).
Systemic EtOH administration increases brain and plasma
allopregnanolone levels to physiologically relevant concen-
trations, capable of enhancing GABAergic transmission and
contribute to sensitivity to behavioral effects of EtOH in rats
(Barbaccia et al., 1999; Morrow et al., 1999; VanDoren
et al., 2000). In fact, allopregnanolone modulates EtOH’s
anticonvulsant effects (VanDoren et al., 2000), sedation
(Khisti et al., 2003), impairment of spatial memory (Mat-
thews et al., 2002), anxiolytic-like (Hirani et al., 2005), anti-
depressant-like (Hirani et al., 2002), and proaggressive
actions (Fish et al., 2001). Allopregnanolone also mediates
EtOH’s ability to inhibit the spontaneous firing of medial
septal neurons (VanDoren et al., 2000) and hippocampal
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pyramidal neurons (Tokunaga et al., 2003) in rats. These
behavioral and electrophysiological responses are inhibited
by pretreatment with finasteride (a 5a-reductase inhibitor)
and/or by prior adrenalectomy. In fact, the EtOH-induced
increase in cerebrocortical allopregnanolone levels is medi-
ated by the hypothalamic–pituitary–adrenal (HPA) axis,
since it is absent following adrenalectomy/gonadectomy
(Khisti et al., 2003; O’Dell et al., 2004; Porcu et al., 2004) or
hypophysectomy (Boyd et al., 2010). However, EtOH can
increase allopregnanolone content in hippocampal slices
from intact and adrenalectomized/gonadectomized rats
(Follesa et al., 2006).
The evidence regarding a role for allopregnanolone in
EtOH’s actions has been mostly obtained in rats. Studies in
mice have mainly focused on C57BL/6J and DBA/2J mice,
two of the most widely used inbred strains in addiction
research because of their different sensitivity to several drugs
of abuse (Belknap et al., 1993a,b). With respect to alcohol,
DBA/2J mice have more severe handling-induced convul-
sions after acute (Roberts et al., 1992) and chronic (Crabbe
et al., 1983) EtOH withdrawal. Further, DBA/2J mice show
greater acute functional tolerance (Gallaher et al., 1996),
locomotor activity (Crabbe et al., 1983), and hypnosis
(Linsenbardt et al., 2009). These strains also differ in EtOH
preference and consumption. In the 2-bottle-choice para-
digm, C57BL/6J mice drink alcohol, while DBA/2J mice
avoid it (Belknap et al., 1977; Phillips et al., 1994). However,
when allowed to self-administer EtOH intravenously, these 2
strains do not differ in the amount of EtOH self-adminis-
tered, suggesting that EtOH’s reinforcing properties are
similar in both strains (Grahame and Cunningham, 1997).
C57BL/6J and DBA/2J mice also differ in the behavioral
response to neuroactive steroids. C57BL/6J mice are more
sensitive to the anxiolytic, locomotor stimulant, and anticon-
vulsant effects of allopregnanolone than DBA/2J mice (Finn
et al., 1997b).
Endogenous allopregnanolone may play a role in sensitiv-
ity to EtOH in these strains. Allopregnanolone modulates
EtOH intake (Ford et al., 2005, 2007) and reinstates EtOH
seeking behavior in C57BL/6J mice (Finn et al., 2008); it is
also thought to modulate EtOH withdrawal severity across
mouse strains (Finn et al., 2004a; Gililland and Finn, 2007).
Acute EtOH administration increases whole brain allopreg-
nanolone levels in male DBA/2J (Gabriel et al., 2004) and
C57BL/6J mice, although in this strain, the effect did not
reach statistical significance (Finn et al., 2004b). Moreover,
we recently reported that a single administration of EtOH
(2 g/kg, i.p.) failed to increase plasma allopregnanolone lev-
els in male DBA/2J mice and it actually decreased them in
male C57BL/6J mice (Porcu et al., 2010). To further explore
these discrepancies and to better understand the effects of
EtOH on brain neurosteroidogenesis in mice, we examined
whether acute EtOH administration alters cerebrocortical
and hippocampal levels of allopregnanolone and progester-
one in C57BL/6J and DBA/2J mice. We further describe the
effects of acute EtOH administration to these strains on
cerebrocortical and hippocampal levels of corticosterone, the




Male C57BL/6J and DBA/2J mice (8 weeks old) were purchased
from Charles River (Calco, Italy). They were housed 5 to 6 per cage
under an artificial 12-hour-light, 12-hour-dark cycle (light on from
08:00 to 20:00 hours), a constant temperature of 22  2°C, and rel-
ative humidity of 65%. They had free access to water and standard
laboratory food throughout the experimental period. Animal care
and handling was in accordance with the European Parliament and
the Council Directive 2010/63/EU. Experimental procedures were
approved by the local ethics committee; all efforts were made to
minimize animal suffering and to reduce the number of animals
used.
Drug Administration
For the dose–response studies, EtOH (1, 2, 3, or 4 g/kg, 20% v/v
in saline) or saline was administered by intraperitoneal (i.p.) injec-
tion, 60 minutes before euthanasia; for the time-course studies, ani-
mals were euthanized 15, 30, 60, and 120 minutes after EtOH
administration (2 g/kg, i.p.); saline-treated mice were euthanized
60 minutes later. Morphine hydrochloride (5, 10, and 30 mg/kg,
expressed as free base; S.a.l.a.r.s., Como, Italy) was dissolved in
saline and administered i.p. in a volume of 3 ml/kg; mice were
euthanized 60 minutes later. Experiments were conducted in the
morning from 09:00 to 11:00 hours to avoid circadian fluctuations
in neuroactive steroid levels (Corpechot et al., 1997). Mice were not
habituated to handling and injection to avoid potential confounds
from differences in habituation across strains, which may influence
a drug’s pharmacological effect (Ryabinin et al., 1999).
Neuroactive Steroid Assay
Animals were euthanized by decapitation, and the brain areas
were rapidly (<1 minute) dissected, frozen on dry ice, and stored at
80°C until steroid extraction. Blood was collected from the trunk
into heparin-coated tubes and centrifuged at 9009g for 15 minutes;
plasma was collected and frozen until assayed for steroids.
Allopregnanolone, progesterone, and corticosterone were extracted
and purified as previously described (Porcu et al., 2004). Briefly, ste-
roids present in cerebrocortical (~150 mg of tissue in 1 ml of phos-
phate-buffered saline) or hippocampal (~30 mg of tissue in 0.3 ml
of phosphate-buffered saline) homogenates were extracted 4 times
with an equal volume of ethyl acetate. The combined organic phases
were dried under vacuum, and the resulting residue was dissolved in
n-hexane and applied to Seppak-silica cartridges (Waters, Milan,
Italy), and residue components were eluted with a mixture of n-hex-
ane:1-propanol (7:3, v/v). Steroids were further purified by high-
performance liquid chromatography (Beckman-Coulter, Cassina
de’ Pecchi, Italy) on a 5-lm LiChrosorb-diol column (250 9 4 mm;
Phenomenex, Castel Maggiore, Italy) with a gradient of 1-propanol
in n-hexane. The recovery of each steroid through the extraction–
purification procedures (70 to 80%) was monitored by adding trace
amounts (~8000 cpm) of 3H-labeled standards (Perkin Elmer, Mon-
za, Italy) to the tissue homogenate. Steroid concentrations were
quantified by radioimmunoassay. Progesterone (purity ≥99%), allo-
pregnanolone (purity ≥99%), and corticosterone (purity ≥98.5%)
were purchased from Sigma-Aldrich (Milan, Italy). Antisera to pro-
gesterone and corticosterone were purchased from MP Biomedicals
(Solon, OH). The progesterone antiserum cross-reacts with
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progesterone 100%, desoxycorticosterone 2.1%, corticosterone
1.4%, 17a-hydroxypregnenolone 1.4%, pregnenolone 0.2%, 20a-
dihydroprogesterone 0.2%, testosterone 0.09%, androstenedione
0.07%, and 11-desoxycortisol 0.05%. The corticosterone antiserum
cross-reacts with corticosterone 100%, desoxycorticosterone 2.3%,
testosterone 0.47%, prednisolone 0.35%, 17a-hydroxyprogesterone
0.33%, cortisol 0.27%, progesterone 0.17%, 11-desoxycortisol
0.14%, 20a-dihydroprogesterone 0.07% and aldosterone 0.05%.
Rabbit antiserum to allopregnanolone was generated and character-
ized by Dr. R.H. Purdy as previously described (Purdy et al., 1990);
it cross-reacts with allopregnanolone 100%, progesterone 17%, and
corticosterone 0% (for a complete cross-reactivity report, see Purdy
et al., 1990). All other reagents and organic solvents (high-perfor-
mance liquid chromatography grade) were of the best available
quality from commercial sources. Intra- and interassay variation
ranged as follows: progesterone 5 to 8 and 9 to 12%, allopregnano-
lone 5 to 7 and 8 to 12%, corticosterone 5 to 7 and 9 to 12%, respec-
tively. The minimal detectable limit is 0.01 ng/g for all steroids.
Progesterone and corticosterone plasma concentrations were
assayed by ELISA (Demeditec Diagnostics, Kiel-Wellsee, Ger-
many). Cross-reactivity for the progesterone assay is: progesterone
100%, pregnenolone 5.5%, 11-desoxycorticosterone 1.8%, 17a-hy-
droxyprogesterone 0.6%, testosterone 0.14%, and corticosterone
0.3%. Cross-reactivity for the corticosterone assay is: corticosterone
100%, 11-desoxycorticosterone 2.4%, progesterone 0.7%, cortisol
0.3%, and aldosterone 0.2%. Intra- and interassay variation ranges
between 5 to 9 and 6 to 8% for progesterone and 3 to 8 and 5 to
12% for corticosterone, respectively. The minimal detectable limit is
0.04 ng/ml for progesterone and 4 ng/ml for corticosterone.
Statistical Analysis
Statistical analysis was performed using a commercially available
statistical program (GraphPad Prism 5.0; GraphPad Software, San
Diego, CA). Data are presented as means  SEM, and statistical
comparisons were performed by 2-way analysis of variance (ANO-
VA) followed by Bonferroni post hoc test. A p-value < 0.05 was
considered statistically significant.
RESULTS
Effects of Acute EtOH Administration on Cerebrocortical and
Hippocampal Levels of Progesterone and Allopregnanolone in
C57BL/6J and DBA/2JMice
Figure 1 shows the effects of EtOH administration on
cerebrocortical concentrations of progesterone and allopreg-
nanolone in C57BL/6J and DBA/2J mice. None of the
EtOH doses examined (1, 2, 3, and 4 g/kg) significantly
affected cerebrocortical levels of progesterone and allopreg-
nanolone in these strains. Two-way ANOVA for progester-
one showed no significant effect of EtOH dose,
F(4, 150) = 0.93, p = 0.45, no significant effect of strain, F(1,
150) = 1.91, p = 0.17, and no interaction, F(4, 150) = 0.13,
p = 0.97. Two-way ANOVA for allopregnanolone showed
no effect of EtOH dose, F(4, 148) = 0.14, p = 0.97, no effect
Fig. 1. Effect of ethanol (EtOH) administration on progesterone (A,B) and allopregnanolone (C,D) levels in the cerebral cortex of C57BL/6J and DBA/
2J mice. EtOH (1, 2, 3, and 4 g/kg, 20% v/v in saline) or saline was administered i.p. 60 minutes before euthanasia. Levels are expressed as nanograms
of steroid per gram of tissue and are average  SEM of values from 16mice per group with the exception of the 3 and 4 g/kg groups for allopregnanolone
levels in DBA/2J mice where n = 15.
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of strain, F(1, 148) = 1.79, p = 0.18, and no interaction,
F(4, 148) = 0.55, p = 0.69.
Likewise, acute EtOH administration did not alter hippo-
campal levels of progesterone and allopregnanolone in
C57BL/6J and DBA/2J mice. Two-way ANOVA for proges-
terone showed no effect of EtOH dose, F(4, 150) = 0.94,
p = 0.44, no effect of strain, F(1, 150) = 0.004, p = 0.95, and
no interaction, F(4, 150) = 0.74, p = 0.56 (Fig. 2A, B). Two-
way ANOVA for allopregnanolone showed no effect of
EtOH dose, F(4, 148) = 1.70, p = 0.15, a significant effect of
strain, F(1, 148) = 10.63, p = 0.001, and no interaction,
F(4, 148) = 0.05, p = 0.99. However, the Bonferroni post hoc
test failed to identify any significant differences between selected
experimental groups within the strains (Fig. 2C,D).
For these experiments, mice were euthanized 60 minutes
after EtOH administration, the optimal time point for the
EtOH-induced increases in neuroactive steroids in rats
(VanDoren et al., 2000). However, EtOH’s actions across
time may differ between species. Thus, we evaluated the
time course for the EtOH-induced changes in neuroactive
steroid levels. Acute EtOH administration (2 g/kg, i.p.) to
C57BL/6J and DBA/2J mice failed to alter cerebrocortical
levels of progesterone and allopregnanolone at any of the
time points examined. Two-way ANOVA for progesterone
showed no effect of time, F(4, 150) = 1.82, p = 0.13, no
effect of strain, F(1, 150) = 2.39, p = 0.12, and no interac-
tion, F(4, 150) = 0.72, p = 0.58 (Fig. 3A, 3B). Two-way
ANOVA for allopregnanolone showed no effect of time, F
(4, 150) = 0.44, p = 0.78, a significant effect of strain,
F(1, 150) = 18.28, p < 0.0001, but no interaction,
F(4, 150) = 0.22, p = 0.93. The post hoc test did not identify
significant differences between selected groups within the
strains (Fig. 3C, D).
Effects of Acute EtOH Administration on Cerebrocortical and
Hippocampal Corticosterone Levels in C57BL/6J and DBA/
2JMice
To determine whether the lack of EtOH’s effects on proges-
terone and allopregnanolone levels might be due to altera-
tions in HPA axis activation in C57BL/6J and DBA/2J mice,
we measured corticosterone levels in the cerebral cortex and
hippocampus. Two-wayANOVA for cerebrocortical cortico-
sterone showed a significant effect of EtOH dose, F(4, 148) =
36.78, p < 0.0001, a significant effect of strain, F(1,
148) = 63.92, p < 0.0001, and a significant interaction,
F(4, 148) = 4.19, p = 0.003. Acute EtOH administration
dose-dependently increased corticosterone levels in the
Fig. 2. Effect of ethanol (EtOH) administration on progesterone (A,B) and allopregnanolone (C,D) levels in the hippocampus of C57BL/6J and DBA/
2J mice. EtOH (1, 2, 3, and 4 g/kg, 20% v/v in saline) or saline was administered i.p. 60 minutes before euthanasia. Levels are expressed as nanograms
of steroid per gram of tissue and are average  SEM of values from 16mice per group with the exception of the 3 and 4 g/kg groups for allopregnanolone
levels in DBA/2J mice where n = 15.
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cerebral cortex of C57BL/6J mice (+319, +347, and +459%,
at the doses of 2, 3, and 4 g/kg, respectively, p < 0.001,
Fig. 4A) and DBA/2J mice (+371, +507, +533, and +692%, at
the doses of 1, 2, 3, and 4 g/kg, respectively, p < 0.001,
Fig. 4B). The post hoc analysis further revealed a significant
difference between strains with respect to EtOH treatment:
The EtOH-induced increase in corticosterone levels was sig-
nificantly greater (p < 0.01) in DBA/2J versus C57BL/6J
mice at all doses examined (Fig. 4A,B).
Two-way ANOVA for hippocampal corticosterone
showed a significant effect of EtOH dose, F(4, 148) = 24.31,
p < 0.0001, no effect of strain, F(1, 148) = 2.86, p = 0.09,
and no interaction, F(4, 148) = 1.09, p = 0.36. Acute EtOH
administration dose-dependently increased hippocampal
corticosterone levels in C57BL/6J (+253, +248, and +387%,
at the doses of 2, 3, and 4 g/kg, respectively, p < 0.001,
Fig. 4C) and DBA/2J mice (+285%, at 1 g/kg, p < 0.01, and
+441, +554, and +661%, at the doses of 2, 3, and 4 g/kg,
respectively, p < 0.001, Fig. 4D).
The effects of EtOH on cerebrocortical corticosterone lev-
els were also time dependent. Two-way ANOVA showed a
significant effect of time, F(4, 150) = 50.66, p < 0.0001, a
significant effect of strain, F(1, 150) = 4.05, p = 0.046, and a
significant interaction, F(4, 150) = 8.20, p < 0.0001. In
C57BL/6J mice, EtOH (2 g/kg, i.p.) increased cerebrocorti-
cal corticosterone levels by +214 and +227% at 15 and
30 minutes, respectively (p < 0.001); corticosterone levels
peaked at 60 minutes (+352%, p < 0.001) and remained ele-
vated at 120 minutes (+263%, p < 0.001) after EtOH
administration (Fig. 5A). In DBA/2J mice, cerebrocortical
corticosterone levels increased at 30 minutes (+507%,
p < 0.001), peaked at 60 minutes (+956%, p < 0.001), and
remained elevated at 120 minutes (+759%, p < 0.001) after
EtOH administration (Fig. 5B). The post hoc analysis
revealed a significant difference between strains with respect
to EtOH treatment: The EtOH-induced increase in cortico-
sterone levels was significantly greater (p < 0.01) in DBA/2J
versus C57BL/6J mice at 60 and 120 minutes; in contrast, at
15 minutes, the effect was greater (p < 0.05) in C57BL/6J
versus DBA/2J mice.
Effects of Acute EtOH Administration on Plasma Levels of
Progesterone and Corticosterone in C57BL/6J and DBA/2J
Mice
We further examined EtOH’s effects on plasma progester-
one and corticosterone levels in C57BL/6J and DBA/2J
mice. Two-way ANOVA for progesterone showed a signifi-
cant effect of time, F(4, 72) = 5.25, p = 0.0009, a significant
effect of strain, F(1, 72) = 36.56, p < 0.0001, but no interac-
tion, F(4, 72) = 0.90, p = 0.47 (Table 1). Acute EtOH (2
g/kg, i.p.) increased plasma progesterone levels in C57BL/6J
Fig. 3. Time course of the cerebrocortical concentrations of progesterone (A,B) and allopregnanolone (C,D) following ethanol (EtOH) administration
in C57BL/6J and DBA/2J mice. Mice were injected with EtOH (2 g/kg, i.p.) at the indicated times before euthanasia. Control mice received an equivalent
volume of saline and were euthanized 60 minutes later. Levels are expressed as nanograms of steroid per gram of tissue and are average  SEM of val-
ues from 16 mice per group.
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mice (+210%, p < 0.001; +173%, p < 0.01; and +230%,
p < 0.001, respectively, at 15, 30, and 60 minutes after
administration). Acute EtOH administration increased
plasma progesterone levels in DBA/2J mice, although this
effect was not statistically significant. The post hoc analysis
also revealed a significant difference between strains with
respect to the EtOH treatment groups at 15, 30, and
60 minutes (p < 0.01).
Acute EtOH administration increased plasma corticoste-
rone levels in both mouse strains (Table 1). Two-way
ANOVA showed a significant effect of time, F(4,
75) = 96.09, p < 0.0001, no effect of strain, F(1, 75) = 0.22,
Fig. 4. Effect of ethanol (EtOH) administration on corticosterone levels in the cerebral cortex (A,B) and the hippocampus (C,D) of C57BL/6J and DBA/
2J mice. EtOH (1, 2, 3, and 4 g/kg, 20% v/v in saline) or saline was administered i.p. 60 minutes before euthanasia. Levels are expressed as nanograms
of steroid per gram of tissue and are average  SEM of values from 16 mice per group with the exception of the 3 and 4 g/kg groups in DBA/2J mice
where n = 15. *p < 0.01 and **p < 0.001 versus the respective saline-treated values; #p < 0.01 versus the respective EtOH-treated groups across
strains; 2-way ANOVA followed by Bonferroni post hoc test.
Fig. 5. Time course of the cerebrocortical concentrations of corticosterone following ethanol (EtOH) administration in C57BL/6J (A) and DBA/2J (B)
mice. Mice were injected with EtOH (2 g/kg, i.p.) at the indicated times before euthanasia. Control mice received an equivalent volume of saline and were
euthanized 60 minutes later. Levels are expressed as nanograms of steroid per gram of tissue and are average  SEM of values from 16 mice per
group. *p < 0.001 versus the respective saline-treated values; #p < 0.05 and ##p < 0.01 versus the respective EtOH-treated groups across strains;
2-way ANOVA followed by Bonferroni post hoc test.
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p = 0.64, and a significant interaction, F(4, 75) = 5.88, p =
0.0004. In C57BL/6J mice, the effect was apparent at 15 min-
utes (+243%, p < 0.001), persisted at 30 minutes (+282%,
p < 0.001), peaked at 60 minutes (+389%, p < 0.001), and
remained elevated at 120 minutes (+243%, p < 0.001). In
DBA/2J mice, the effect was apparent at 15 minutes (+272%,
p < 0.001), persisted at 30 minutes (+434%, p < 0.001),
peaked at 60 minutes (+742%, p < 0.001), and remained dra-
matically elevated at 120 minutes (+557%, p < 0.001).
Effects of Acute Morphine Administration on Cerebrocortical
Levels of Progesterone and Allopregnanolone in C57BL/6J
and DBA/2JMice
Given that acute EtOH failed to alter cerebrocortical and
hippocampal levels of progesterone and allopregnanolone,
despite a robust HPA axis activation and subsequent
increased corticosterone levels, we further evaluated whether
the lack of neurosteroidogenesis in C57BL/6J and DBA/2J
mice was specific to EtOH. We thus examined the effects of
acute morphine administration, which also increases neuro-
active steroids in rat cerebral cortex (Concas et al., 2006).
Two-way ANOVA for cerebrocortical progesterone levels
showed a significant effect of morphine dose, F(3, 70) =
10.78, p < 0.0001, a significant effect of strain, F(1,
70) = 12.08, p = 0.0009, and a significant interaction, F(3,
70) = 4.61, p = 0.005. Acute morphine administration
increased progesterone levels in C57BL/6J (+117 and
+107%, respectively, at 10 and 30 mg/kg, p < 0.001,
Fig. 6A) and DBA/2J mice (+57 and +62%, respectively, at 5
and 10 mg/kg, p < 0.01, Fig. 6B). The post hoc analysis
revealed a significant difference (p < 0.001) between strains
at the 5 mg/kg dose, with the effect being apparent in DBA/
2J, but not C57BL/6J mice (Fig. 6A, B).
Two-way ANOVA for cerebrocortical allopregnanolone
levels showed a significant effect of morphine dose, F(3, 72)
= 12.60, p < 0.0001, a significant effect of strain, F(1, 72)
= 87.35, p < 0.0001, and a significant interaction,
F(3, 72) = 3.61, p = 0.017. Acute morphine administration
increased allopregnanolone levels in C57BL/6J mice (+77, +93
and +88%, respectively, at 5, 10, and 30 mg/kg, p < 0.001,
Fig. 6C), while in DBA/2J mice levels were increased only at
5 mg/kg (+81%, p < 0.05, Fig. 6D). The post hoc analysis
revealed a significant difference (p < 0.001) between strains
for all the doses of morphine tested, with an overall greater
effect in C57BL/6J versusDBA/2Jmice (Fig. 6C,D).
DISCUSSION
Several studies have shown that acute EtOH administra-
tion increases brain and plasma levels of allopregnanolone
and its precursor progesterone in rats (Barbaccia et al., 1999;
Morrow et al., 1999; VanDoren et al., 2000) and that EtOH-
induced elevations in allopregnanolone concentrations con-
tribute to sensitivity to behavioral and electrophysiological
effects of EtOH (Morrow et al., 2006). We recently reported
that acute EtOH administration did not alter serum allopreg-
nanolone concentrations in DBA/2J mice and it actually
decreased them in C57BL/6J mice (Porcu et al., 2010). We
further observed that acute EtOH administration did not
alter serum allopregnanolone concentrations in cynomolgus
monkeys and humans, suggesting that there might be impor-
tant species differences in the neurosteroidogenic effects of
EtOH (Porcu et al., 2010). Thus, we examined the effects of
acute EtOH administration on cerebrocortical and hippo-
campal neuroactive steroid concentrations in na€ıve C57BL/
6J and DBA/2J male mice, given that these are 2 inbred
strains most widely used in alcoholism research, which have
been characterized extensively in terms of their behavioral
sensitivity to EtOH (Belknap et al., 1993b; Crabbe et al.,
1983; Gallaher et al., 1996; Linsenbardt et al., 2009; Roberts
et al., 1992). We found that acute EtOH administration did
not alter cerebrocortical and hippocampal concentrations of
allopregnanolone and progesterone in na€ıve C57BL/6J and
DBA/2J mice at any of the doses and time points examined.
Previous studies on the neurosteroidogenic effects of acute
EtOH in mice have focused on C57BL/6J and DBA/2J
strains. EtOH administration (2 g/kg) increased whole brain
allopregnanolone concentrations in DBA/2J mice that,
3 weeks before this experiment, underwent an EtOH-
induced conditioned place preference test (Gabriel et al.,
2004), which may have influenced stress and EtOH
Table 1. Time Course of the Plasma Concentrations of Progesterone and Corticosterone Following Ethanol (EtOH) Administration in C57BL/6J and
DBA/2J Mice
Progesterone Corticosterone
C57BL/6J DBA/2J C57BL/6J DBA/2J
Saline 1.84  0.54 0.37  0.08 50.9  6.97 34.4  6.95
15 min 5.71  0.62** 1.80  0.42# 174.3  8.87** 127.8  9.35**
30 min 5.04  0.79* 1.77  0.55# 194.6  11.27** 183.5  9.39**
60 min 6.08  1.21** 2.74  0.14# 248.6  12.32** 289.3  14.06**
120 min 3.81  1.06 1.78  0.35 174.5  19.70** 225.7  13.74**
Mice were injected with EtOH (2 g/kg, i.p.) at the indicated times before euthanasia. Control mice received an equivalent volume of saline and were
euthanized 60 minutes later. Levels are expressed as nanograms of steroid per milliliter of plasma and are average  SEM of values from 9 C57BL/6J
mice per group and from 8 DBA/2J mice per group with the exception of the saline-treated group for progesterone levels where n = 5.
*p < 0.01 and **p < 0.001 vs the respective saline-treated group, #p < 0.01 vs the respective EtOH-treated groups across strains; 2-way ANOVA
followed by Bonferroni post hoc test.
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responses. Acute EtOH administration also increased brain
allopregnanolone levels in C57BL/6J mice, although this
effect did not reach statistical significance, perhaps because
data in this experiment were combined from grouped-housed
and isolated mice (Finn et al., 2004b). Given that social iso-
lation influences EtOH sensitivity (Serra et al., 2003), we
cannot rule out the possibility that isolated C57BL/6J mice
actually show a neurosteroidogenic response to EtOH, as
opposed to group-housed ones, which may have influenced
the above mentioned findings. Our experiments were per-
formed in na€ıve group-housed nonhandled mice, to avoid
potential confounds from previous experimental manipula-
tion and from differences in handling habituation across
C57BL/6J and DBA/2J strains that may influence a drug’s
pharmacological effect (Ryabinin et al., 1999). Furthermore,
methodological differences in measurement of allopregnano-
lone levels (whole brain vs. selected areas, tissue purification,
and antibody used for the radioimmunoassay) might also
contribute to the discrepancies between our results and those
previously reported. Additionally, in DBA/2J mice, EtOH
may promote neurosteroidogenesis in brain regions other
than the cerebral cortex and the hippocampus, which might
account for the increase in whole brain allopregnanolone
content reported by Gabriel and colleagues (2004). Indeed,
differential effects of EtOH on immunohistochemical label-
ing of allopregnanolone content have been recently reported
across several rat brain regions (Cook et al., 2013).
We previously reported that acute EtOH administration
did not alter serum allopregnanolone concentrations in
DBA/2J mice, but it actually decreased them in C57BL/6J
mice (Porcu et al., 2010). Serum allopregnanolone concen-
trations were measured by gas chromatography–mass spec-
trometry, a highly sensitive and specific method, which
detects trace amounts of neuroactive steroids in a small
volume of sample like the one that can be obtained from a
mouse. Differences in the methodology (gas chromatogra-
phy–mass spectrometry vs. radioimmunoassay) might
contribute to the discrepancy on the EtOH-induced changes
in allopregnanolone content in serum versus cerebral cortex
and hippocampus. However, these differential effects of
EtOH might also be due to the tissue specificity (serum vs.
brain). In the present study, we were unable to measure al-
lopregnanolone levels in serum by radioimmunoassay, due
to the small amount of sample obtained from a mouse.
However, we did measure progesterone levels in plasma
using a commercially available kit that requires small
amounts of sample. EtOH administration (2 g/kg)
increased plasma progesterone levels in a time-dependent
Fig. 6. Effect of morphine administration on progesterone (A,B) and allopregnanolone (C,D) levels in the cerebral cortex of C57BL/6J and DBA/2J
mice. Morphine (5, 10, and 30 mg/kg, in saline) or saline was administered i.p. 60 minutes before euthanasia. Levels are expressed as nanograms of ste-
roid per gram of tissue and are average  SEM of values from 11 C57BL/6J mice per group and from 9 DBA/2J mice per group with the exception of the
5 mg/kg group for progesterone levels where n = 7. *p < 0.05, **p < 0.01, and ***p < 0.001 versus the respective saline-treated values; #p < 0.001
versus the respective morphine-treated groups across strains; 2-way ANOVA followed by Bonferroni post hoc test.
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manner, in C57BL/6J and DBA/2J mice, although the effect
on DBA/2J mice did not reach statistical significance.
Indeed, the same treatment failed to affect cerebrocortical
progesterone levels, suggesting that EtOH is regulating
peripheral, but not central neurosteroidogenesis in na€ıve
C57BL/6J mice.
The doses of EtOH tested in our experiments increase
blood alcohol levels in C57BL/6J and DBA/2J mice to values
comparable to the ones reported in rats and sufficient to
increase neuroactive steroids (Porcu et al., 2010). EtOH
metabolism is faster in mice than in rats (Abel, 1982); how-
ever, EtOH fails to alter cerebrocortical and hippocampal
allopregnanolone levels in C57BL/6J and DBA/2J mice even
at early time points, suggesting that the neurosteroidogenic
properties of EtOH in the cerebral cortex and the hippocam-
pus may be species specific.
The lack of effects of EtOH on allopregnanolone levels in
na€ıve C57BL/6J and DBA/2J mice suggests that alterations
in endogenous allopregnanolone concentrations, in contrast
to what happens in rats (Morrow et al., 2006), do not appear
to modulate EtOH’s behavioral effects in these strains, and
therefore, endogenous allopregnanolone might not account
for the differences in EtOH sensitivity observed in C57BL/6J
versus DBA/2J mice. However, previous studies have sug-
gested that allopregnanolone may indeed play a role in
EtOH’s actions, independent from its steroidogenic effects.
In fact, allopregnanolone administration to C57BL/6J mice
modulates EtOH self-administration (Ford et al., 2005,
2007) and reinstates EtOH seeking behavior (Finn et al.,
2008). Likewise, allopregnanolone administration modulates
EtOH self-administration in rats (Janak et al., 1998). Fur-
thermore, neuroactive steroids modulate EtOH withdrawal
severity in several mouse strains (Finn et al., 2004a; Gililland
and Finn, 2007). However, allopregnanolone, despite having
reinforcing properties in DBA/2J mice (Finn et al., 1997a),
does not alter EtOH conditioned place preference in this
strain (Gabriel et al., 2004).
The EtOH-induced increase in allopregnanolone content
contributes to some behavioral effects of EtOH in rats,
including anticonvulsant, sedative, and anxiolytic actions,
as well as learning and memory (Morrow et al., 2006).
Acute EtOH administration induces similar effects in mice,
but fails to alter allopregnanolone levels, suggesting that
different mechanisms could mediate similar effects in rats
and mice. EtOH has pleiotropic actions on several neuro-
modulators and neurotransmitters; we can hypothesize that
the EtOH-induced increase in allopregnanolone content in
rats may contribute to EtOH sensitivity to a greater extent
than other neuromodulators; in contrast, other systems
may be more prominent in mice. For instance, the EtOH
metabolite acetaldehyde also influences EtOH’s effects.
Concentrations of acetaldehyde such as those induced by
EtOH administration (2 g/kg, i.p.) did not increase allo-
pregnanolone levels in rats (Boyd et al., 2008). However,
acetaldehyde has been found to mediate behavioral effects
of EtOH in rats as well as C57BL/6J mice (Quertemont
et al., 2004), suggesting that its effects may be independent
of EtOH-induced neurosteroidogenesis. We cannot rule out
the possibility that the EtOH-induced increase in allopreg-
nanolone and the concomitant presence of acetaldehyde
may both participate in the sensitivity to EtOH’s behavioral
effects. Allopregnanolone may have a more prominent role
in rats, while acetaldehyde may have more significance in
mice. Future studies may address these hypotheses.
In C57BL/6J mice, neurosteroids are required to activate
the HPA axis in response to stress, whereby they promote a
collapse of the chloride gradient resulting in excitatory GAB-
Aergic transmission at the level of the corticotrophin-releas-
ing hormone neurons in the hypothalamus (Sarkar et al.,
2011). The failure of acute EtOH to increase cerebrocortical
and hippocampal allopregnanolone levels may suggest an
impairment in EtOH-induced HPA axis activation in
C57BL/6J and DBA/2J mice. To evaluate EtOH’s activation
of the HPA axis in na€ıve C57BL/6J and DBA/2J mice, we
measured corticosterone levels, and we found that acute
EtOH administration, dose- and time-dependently, increased
corticosterone levels in the cerebral cortex, hippocampus,
and plasma, suggesting that EtOH administration is activat-
ing the HPA axis. This is the first evidence of brain cortico-
sterone alterations in these 2 mouse strains. This result is in
agreement with a previous report showing an increase in
brain corticosterone concentrations following acute EtOH
administration in male Tuck-Ordinary (TO) mice (Croft
et al., 2008). Hippocampal corticosterone levels were also
increased in TO mice following long-term EtOH withdrawal
(Little et al., 2008). Overall, these results suggest that EtOH
stimulates the HPA axis and promotes corticosterone synthe-
sis not only in the periphery, as was previously shown (Rob-
erts et al., 1992), but also in the cerebral cortex and the
hippocampus of both mouse strains.
Corticosterone is the main steroid produced by adrenal
glands in response to HPA axis activation and is a progester-
one metabolite. Thus, it is quite unusual that EtOH induced
an increase in corticosterone levels in brain without altering
levels of its precursor. The mechanism by which EtOH is
exerting this effect is still unclear. Perhaps EtOH may selec-
tively alter cerebrocortical and hippocampal steroidogenesis
in a manner that produces corticosterone, rather than pro-
gesterone from pregnenolone. However, plasma progester-
one levels were increased following acute EtOH
administration in C57BL/6J mice. At present, we cannot rule
out the possibility that acute EtOH administration may have
differential effects on steroidogenic enzymes in the adrenals
and brain of these mouse strains.
The lack of effects of EtOH on cerebrocortical allopreg-
nanolone and progesterone concentrations in na€ıve C57BL/
6J and DBA/2J mice appears to be specific to EtOH, given
that administration of morphine increases cerebrocortical al-
lopregnanolone levels in these strains. Morphine increased
cerebrocortical concentrations of allopregnanolone and pro-
gesterone in male Sprague–Dawley rats, starting at the dose
of 10 mg/kg (Concas et al., 2006). Likewise, in C57BL/6J
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mice, morphine significantly increased cerebrocortical levels
of progesterone, in a manner similar to that reported in rats.
Cerebrocortical allopregnanolone levels in C57BL/6J mice
increased starting at the dose of 5 mg/kg, suggesting that this
strain might be even more sensitive than Sprague–Dawley
rats to the neurosteroidogenic effects of morphine, although
morphine increased allopregnanolone levels to a slightly
greater extent in rats than C57BL/6J mice. Morphine admin-
istration also increased progesterone and allopregnanolone
levels in the cerebral cortex of DBA/2J mice, although the
effect was less pronounced compared with the one observed
in C57BL/6J mice, suggesting that these strains have a differ-
ent sensitivity to the morphine-induced increases in cerebro-
cortical allopregnanolone levels.
In conclusion, these results demonstrate that acute EtOH
administration increases corticosterone levels but does not
alter allopregnanolone and progesterone concentrations in
the cerebral cortex and the hippocampus of na€ıve C57BL/6J
and DBA/2J mice, in contrast to what has been observed in
rats or in whole brain of DBA/2J mice. Our observations
may suggest important species differences in the effects of
EtOH on brain neurosteroidogenesis. Furthermore, given
that acute EtOH administration does not increase cerebro-
cortical and hippocampal allopregnanolone levels in C57BL/
6J and DBA/2J mice, the different sensitivity that these
strains have to acute EtOH’s behavioral effects might not be
directly related to neuroactive steroid responses. Finally, the
lack of effects of EtOH on cerebrocortical neurosteroidogen-
esis in C57BL/6J and DBA/2J mice appears to be an effect
selective for EtOH, given that morphine administration
increases cerebrocortical allopregnanolone levels in these
strains.
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